Sementino, E., Hassan, D., Bellacosa, A
More people hit bigger weight-loss milestones A larger share of tirzepatide users reach 10%, 15%, and 20%+ total weight loss than semaglutide users at comparable time points, though plenty of people reach those same milestones on semaglutide too individual response varies a lot
Wegovy comes in a pre-filled pen that makes the injection process simple
Special Conditions Require Attention- Those with specific conditions such as eye problems, Lebers disease, kidney or liver disease, iron or folic acid deficiency, infections, or undergoing bone marrow-affecting treatments should seek professional advice